These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 17109715)
21. Treatment of clozapine-associated tardive dyskinesia. Lin CC; Bai YM; Chen JY; Wang YC; Liou YJ Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):599-600. PubMed ID: 17920744 [No Abstract] [Full Text] [Related]
22. Pharmacokinetics and safety of combination therapy with lithium and risperidone. Demling JH; Huang ML; Remmerie B; Mannaert E; Sperling W Pharmacopsychiatry; 2006 Nov; 39(6):230-1. PubMed ID: 17124646 [No Abstract] [Full Text] [Related]
23. Acute dyskinesia on starting methylphenidate after risperidone withdrawal. Hollis CP; Thompson A Pediatr Neurol; 2007 Oct; 37(4):287-8. PubMed ID: 17903675 [TBL] [Abstract][Full Text] [Related]
24. Risperidone alone versus risperidone plus valproate in the treatment of patients with schizophrenia and hostility. Citrome L; Shope CB; Nolan KA; Czobor P; Volavka J Int Clin Psychopharmacol; 2007 Nov; 22(6):356-62. PubMed ID: 17917554 [TBL] [Abstract][Full Text] [Related]
25. Choice of and decreasing of the dosage of risperidone in the treatment of schizophrenia. Global versus individual criteria. Gómez-Perretta C Actas Esp Psiquiatr; 2007; 35(1):77-8. PubMed ID: 17323229 [No Abstract] [Full Text] [Related]
26. Effect of ritanserin, a 5HT2A/2C antagonist, on negative symptoms of schizophrenia: a double-blind randomized placebo-controlled study. Akhondzadeh S; Malek-Hosseini M; Ghoreishi A; Raznahan M; Rezazadeh SA Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1879-83. PubMed ID: 18801405 [TBL] [Abstract][Full Text] [Related]
33. Amisulpride versus risperidone in the treatment of depression in patients with schizophrenia: a randomized, open-label, controlled trial. Kim SW; Shin IS; Kim JM; Lee SH; Lee JH; Yoon BH; Yang SJ; Hwang MY; Yoon JS Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct; 31(7):1504-9. PubMed ID: 17692448 [TBL] [Abstract][Full Text] [Related]
34. Schizophrenia in a 5-year-old. Einfeld SL; Andrews D; Selig R; Williams G; Smith C Aust N Z J Psychiatry; 2005 Apr; 39(4):312. PubMed ID: 15777373 [No Abstract] [Full Text] [Related]
35. Effects of haloperidol and risperidone on cerebrohemodynamics in drug-naive schizophrenic patients. Lee SM; Chou YH; Li MH; Wan FJ; Yen MH J Psychiatr Res; 2008 Mar; 42(4):328-35. PubMed ID: 17412363 [TBL] [Abstract][Full Text] [Related]
36. Risperidone-associated increase in triglyceride levels. Weinbrenner A; Peus V; Inta D; Englisch S; Zink M Am J Psychiatry; 2009 Jan; 166(1):113-4. PubMed ID: 19122019 [No Abstract] [Full Text] [Related]
37. Increased plasma brain-derived neurotropic factor, not nerve growth factor-Beta, in schizophrenia patients with better response to risperidone treatment. Lee BH; Kim YK Neuropsychobiology; 2009; 59(1):51-8. PubMed ID: 19270464 [TBL] [Abstract][Full Text] [Related]
38. [Risperidone use in child and adolescent psychiatric patients]. Chevreuil C; Reymann JM; Frémaux T; Polard E; Séveno T; Bentué-Ferrer D Therapie; 2008; 63(5):359-75. PubMed ID: 19154706 [TBL] [Abstract][Full Text] [Related]
39. Time to rehospitalization of clozapine versus risperidone in the naturalistic treatment of comorbid alcohol use disorder and schizophrenia. Kim JH; Kim D; Marder SR Prog Neuropsychopharmacol Biol Psychiatry; 2008 May; 32(4):984-8. PubMed ID: 18262321 [TBL] [Abstract][Full Text] [Related]
40. Effects of risperidone on lipid profile. Khalili H; Dashti-Khavidaki S; Okhovatpour H; Ghaeli P Ann Pharmacother; 2007 May; 41(5):899-900. PubMed ID: 17426072 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]